Intraarterial Alteplase Versus Placebo After Mechanical Thrombectomy
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.
Also called NCT03876119
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 121 participants
- Sponsor
- Registry
-
NCT03876119
-
- Main results
- Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT03876119. Randomized; quadruple masking; primary purpose treatment. Start 2018-12-05 (actual); primary completion 2021-05-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intraarterial Alteplase Versus Placebo After Mechanical Thrombectomy
- Acronym
- CHOICE
- Condition
- Stroke, Acute
- Intervention (Drug)
- Intraarterial alteplase
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hospital Clinic of Barcelona
- Collaborator
- Fundació La Marató de TV3
- Collaborator
- Fundacion Clinic per a la Recerca Biomédica
Record details
- Record id
cardio:ct-nct03876119- Content hash
b8e28ed18effdca53bda9d00f7014cd9b0c3ab9bc0180547d6e2784614df4562